Variant Bio
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1150 Eastlake Ave E Ste 1000, Seattle, W...Phone Number
(650) 270-6137Website
www.variantbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Variant Bio
Variant Bio is dedicated to developing life-saving therapies through the study of genes from individuals with exceptional health-related traits. The company employs insights from human genetics to enhance drug development, significantly increasing the success rates of clinical trials. With a diverse, cross-disciplinary team, they prioritize ethical practices in genomics research, ensuring respect for communities and their data. Variant Bio aims to transform drug discovery while fostering benefit-sharing programs with partner populations.Explore more
Variant Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Variant Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Variant Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Variant Bio had a recent Job posting/layoffs
Check if Variant Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Variant Bio has new funding data
Product Launch: Get notified when Variant Bio launches new products
Website visits: Recent activity has been detected on your website
Check out if Variant Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Variant Bio
Earning: See what the market has to say on Variant Bio recently announced quarterly report
Recommended Actions
Find VP level buyers at Variant Bio
Find 2 more new buyers
Compare Similar Companies to Variant Bio
Compare insights from companies similar to Variant Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Variant Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Variant Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Variant Bio.
Variant Bio Tech Stack
A closer look at the technologies used by Variant Bio
Most Recent Scoops
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
New Hire
Executive Move
Variant Bio News & Media
Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform
Platform integrates proprietary and public genetic and multi-omic data with cutting-edge AI to transform drug discovery Inference Agents autonomously execute PhD-level analyses using Model Context Protocol (MCP) Platform now available to pharmaceutical research partners; powers...Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease
Multi-year alliance leveraging Variant Bio's AI-powered Inference platform to discover novel drug targets for kidney disease Financial terms include upfront, license, and milestone payments potentially exceeding $120 million SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a...Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M
Variant Bio today announced a partnership with Novo Nordisk for disease research and development that could total $50 million for the biotech startup. The Seattle company is working with genetically diverse populations around the world in the pursuit of new drug therapies. The company has built a platform that uses statistical genetics and machine learning to identify the most promising treatments. The multi-year collaboration with Novo Nordisk is focused on using genomic information in treatingVariant Bio Announces Multi-Year Research Partnership with Novo Nordisk to Discover Novel Targets for Metabolic Disease
Collaboration leverages Variant Bio's innovative VB-Inference Platform and expertise partnering with global populations Commercial terms include an upfront payment and additional near-term R&D funding totaling up to $50 million, plus potential option and milestone payments SEATTLE, Jan....
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Variant Bio
Sign Up For FreeTo access detailed company insights
Variant Bio is dedicated to developing life-saving therapies through the study of genes from individuals with exceptional health-related traits. The company employs insights from human genetics to enhance drug development, significantly increasing the success rates of clinical trials. With a diverse, cross-disciplinary team, they prioritize ethical... Read More
